This inventor holds 1 USPTO granted patent. Top assignee: Erasmus University Rotterdam. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Ben A Oostra: Innovator in Hemochromatosis Research
Introduction
Ben A Oostra is a notable inventor based in Bergschenhoek, Netherlands. He has made significant contributions to the field of genetics and medicine, particularly in the study of hemochromatosis, a genetic disorder that affects iron metabolism in the body.
Latest Patents
Oostra holds a patent for "Diagnostics and therapeutics for autosomal dominant hemochromatosis." This invention focuses on the gene and mutations responsible for hemochromatosis (HH). Specifically, it highlights the presence of mutations on the ferroportin 1 (SLC11A3) gene, which leads to abnormal iron transport. The patent also encompasses methods for developing diagnostic tools, drugs, and therapies aimed at treating patients with HH or anemia. He has 1 patent to his name.
Career Highlights
Ben A Oostra is affiliated with Erasmus University Rotterdam, where he conducts research and contributes to advancements in medical science. His work has been pivotal in understanding the genetic underpinnings of hemochromatosis and its implications for patient care.
Collaborations
Oostra has collaborated with esteemed colleagues, including Cock M Van Duijn and Peter Heutink. These partnerships have enhanced the research efforts in the field of genetics and therapeutics.
Conclusion
Ben A Oostra's innovative work in the diagnosis and treatment of hemochromatosis exemplifies the impact of genetic research on medicine. His contributions continue to pave the way for advancements in therapeutic strategies for patients suffering from this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile